A 2025 meta-analysis in Frontiers in Nutrition examined multiple trials comparing ketogenic diets (very low-carb, high-fat) with standard diets in cancer patients. The ketogenic group experienced significantly reduced fat mass and visceral fat, lower blood glucose and insulin, and improvements in LDL, total cholesterol, as well as fatigue and insomnia.